High Consumer Acceptance Shall Pace the Global Over the Counter (OTC) Drugs Market

Global Over the Counter (OTC) Drugs Market Report, published by Variant Market Research, forecast that the global market is expected to reach $273 billion by 2024 from $125 billion in 2016; growing at a CAGR of 10.2% from 2016 to 2024. By geography, Asia-Pacific and Europe are expected to grow at a CAGR of 10.8% and 10.4%, respectively, during the forecast period.
The factors supporting growth of the global OTC market are, rising consumer awareness towards therapeutics of minor health issues, and convenience in direct purchase. Moreover, instantaneous availability and high consumer acceptance are boosting the growth of the market. However, some drug adverse effect owing to wrong administration and lack of knowledge amongst illiterate consumers mainly in the rural areas, would restrain the market growth. Additionally, enlargement in untapped markets of developing countries and novel product innovation would provide several growths opportunities for the market during the forecast period.
The global Over the Counter drugs market has been categorized into type and geography. By type the market is categorized into dermatological products, flu products, analgesic & pain relievers, cough, vitamin supplements, cold, ophthalmic products mineral supplements, and others.The ophthalmic products segment is bifurcated into glaucoma, infective drugs, dry eye, allergic, and other treatments.
Geographically, the market is segregated into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America accounted for the largest market share in the year 2016, driven by huge importunity for OTC drugs in the U.S. Asia-Pacific accounted for around one third of the global market share due to rising consumer awareness in developing nation such as China and Japan. Asia-Pacific is anticipated to attain at the fastest CAGR of 10.8% during the forecast period 2016-2024.
The Major key players operating in the global Over the Counter (OTC) Drugs Market are Vigamox,, Merck KGaA, Lucentis, Restacis, Bayer AG, Sanofi, Teva Pharmaceutical Industries Ltd.,  Alkem Laboratories Limited, Johnson & Johnson Inc., GlaxoSmithKline Plc, Pfizer Inc., and Novartis AG, among others.
Variant Market Research LLP was delineated in 2015 and to launch our business and website it grabbed more than a year. Our head office is based in Pune and we also have branch in San Francisco, California, the U.S. The long time was generally used to build up a talented team of experienced professionals and analysts, to generate client satisfying exact market analysis data. The company aims to be a specialist in delivering reports on various domains with precise analysis, keeping a virtuous relationship with our consumers. Our vision says, "We would like to grow with you, making your paths simpler yet solidest" and our mission is to "Implementing our analytical, technical and marketing skills to set a new goal for our consumers, dedicatedly helping them take their next strategic moves."
The Co-founders of Variant Market Research: M/S Shweta Shubham and Mr. Yogesh Godse are keen to provide services across aforementioned domains helping them to take their strategic moves regarding their business and providing them the growth opportunities. The Co-founders say, "We believe in providing the future solutions for your business, exploring the current market trends and suggesting you the future strategies and forecast of a particular market that could keep your company ahead in the competitive market rivalry." We hold expertise in our designated areas of research and consulting with a team of experts from each of the dedicated areas covered under our research. Destined by the dedicated team of analysts and experts, we are envisioned to provide you our best in order to plan your next strategic move and take your company's future ahead with our support and your esteemed cooperation.
For information, contact:
VARIANT MARKET RESEARCH LLP
Address: 649 Mission St., 5th Floor, San Francisco, CA 94105, United States.
Tel: +1-415-680-2785

Fax: +1-415-680-2786

No comments:

Post a Comment

Global Depression Drug Market Is Boosted By Growing Awareness Regarding Depression

Global Depression Drug Market  Report , published by Variant Market Research, forecast that the global market was valued at $15 billion...